blood clots and semaglutide GLP-1 RA's Increase Clot Risks Blood Clots From Ozempic Kill

Seek urgent medical assistance if you develop: severe and persistent abdominal pain repeated vomiting or inability to keep fluids down swelling of the face, lips, tongue or throat difficulty breathing severe dizziness, confusion or fainting sudden loss or rapid deterioration of vision symptoms of severe low blood sugar when using insulin or a sulphonylurea Suspected adverse reactions can also be reported through the MHRA Yellow Card scheme

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA)

Using different injection sites can help you avoid skin problems

Their accessibility and trained healthcare personnel ensure patient support, adherence to treatment regimens, and improved health outcomes